A new analysis from Leafreport found a 5,100% difference between the cheapest and most expensive CBD products on the market but found a 1.96% price decrease per milligram of CBD since last April.

The report shows the cheapest CBD category is CBD isolate, which Leafreport found was 19% cheaper on average compared to April 2021, while capsules have increased the most over the same period by 2.55%.

Laura Fuentes, chief officer of science and innovation at Green Roads CBD, told Leafreport that when the pricing of the top industry players is considered, “the pricing gap isn’t that big because most follow the same production process and have similar costs.”

“The gap starts showing when companies who fly under the radar and don’t follow generally accepted manufacturing procedures turn up with lower prices – consumers should be wary of pricing that seems too good to be true.” Fuentes to Leafreport

According to Leafreport, the most expensive CBD brand on the market is Kushly, while Industrial Hemp Farms had the most affordable products. The analysis suggests “a massive chasm” separating the most expensive and cheapest CBD products.

The report found that the average price for gummies, capsules, and full and broad-spectrum tinctures was $0.09 per milligram, while the average price for topicals was $0.20 per milligram. Isolates carried an average price of $0.02 per milligram while isolate tinctures cost $0.08 per milligram. According to the report, the average price per milligram of CBD for liquids and vapes ran $0.12 per milligram, and edibles cost $0.17 per milligram.

Edibles designed for pets tracked by Leafreport averaged $0.21 per milligram of CBD, while tinctures designed for pets cost $0.12 per milligram. The difference between product pricing was 1,483% for pet edibles, and 858% for pet tinctures, the report says.

The widest product price gap was in the topicals category, where the price gap per milligram was 11,142%, with a $0.015 per milligram lowest price point and a $1.68625 peak.

Get daily cannabis business news updates. Subscribe








Have an additional perspective to share? Send us a message to let us know, and if your comment is chosen by our editors it could be featured here.























Source link

Medical Disclaimer:

The information provided in these blog posts is intended for general informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. The use of any information provided in these blog posts is solely at your own risk. The authors and the website do not recommend or endorse any specific products, treatments, or procedures mentioned. Reliance on any information in these blog posts is solely at your own discretion.

0 Shares:
Leave a Reply
You May Also Like
Read More

State Policy Weekly Update 3/11/2022

This week’s update highlights important legalization advancements in Delaware and in Pennsylvania as well as updates on several…